Literature DB >> 30806316

Impact of Active Antihyperglycemic Components as Herbal Therapy for Preventive Health Care Management of Diabetes.

Harsha Kashyap1, Sarika Gupta1, Renu Bist1.   

Abstract

Diabetes is a metabolic hyperglycemic condition that progressively develops, effect small and large sensory fibers in the affected population. It has various complications as hypertension, coronary artery disease, stroke, blindness, kidney disease as well as peripheral neuropathy. Sulfonylureas, thiazolidinediones, metformin, biguanidine, acarbose and insulin are commonly used drugs for diabetic patients, but these all have certain side effects. Even metformin, that is known as the miracle drug for diabetes has been found to be associated with side effects, as during treatment it involves complications with eyes, kidneys, peripheral nerves, heart and vasculature. In the present article, we hypothesize recent discoveries with respect to active ingredients from Indian medicinal plants i.e., polypeptide-p (protein analogue act as artificial insulin), charantin (a steroidal saponin), momordicin (an alkaloid) and osmotin (ubiquitous plant protein and animal analogue of human adeponectin) possessing anti-hyperglycemic potential for diabetes type II. Therefore, plants as herbal therapy have preventive care of hyperglycemia accompanied with healthy lifestyle which can provide significant decline in the incidences of diabetes in future. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Diabetes; anti-hyperglycemic; diabetic neuropathy; diacylglycerol; herbal therapy; preventive health care management.

Mesh:

Substances:

Year:  2019        PMID: 30806316     DOI: 10.2174/1566524019666190219124301

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  1 in total

1.  Islet Transplantation Attenuating Testicular Injury in Type 1 Diabetic Rats Is Associated with Suppression of Oxidative Stress and Inflammation via Nrf-2/HO-1 and NF-κB Pathways.

Authors:  Xiandong Zhu; Feixia Guo; Hengjie Tang; Chongchu Huang; Gangyin Xie; Tingting Huang; Yonglin Li; Chengyang Liu; Hongwei Wang; Bicheng Chen
Journal:  J Diabetes Res       Date:  2019-09-05       Impact factor: 4.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.